Pharmesis International Ltd

BFK

Company Profile

  • Business description

    Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its operating segments are Western drugs, which are chemically formulated drugs and are marketed under the Kinna brand; TCM-formulated drugs, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution, which refers to agency products and internally manufactured products which are marketed through the distribution arm. The company derives revenue from the sale of medicines to domestic customers in China.

  • Contact

    5 Kallang Sector
    No. 03-02
    Singapore349279
    SGP

    T: +65 68460766

    https://www.pharmesis.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

Stocks News & Analysis

stocks

AI stocks post big gains in Q3. These are the winners and losers

Alphabet and Teradyne post big gains, while Salesforce and Adobe were down in the quarter.
stocks

12 picks for an income portfolio - Q3 2025 update

Fifteen months in and passive income growth has exceeded my target.
stocks

ASX’s only dividend aristocrat reports

Cyclical headwinds persist but loan book and industrial property prop up earnings.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,280.0038.90-0.42%
CAC 407,971.78109.76-1.36%
DAX 4024,378.290.51-0.00%
Dow JONES (US)46,694.9763.31-0.14%
FTSE 1009,479.1412.11-0.13%
HKSE26,957.77183.15-0.67%
NASDAQ22,941.67161.160.71%
Nikkei 22547,944.762,175.264.75%
NZX 50 Index13,489.2424.85-0.18%
S&P 5006,740.2824.490.36%
S&P/ASX 2008,981.4034.80-0.39%
SSE Composite Index3,882.7820.250.52%

Market Movers